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A coupled transcription-translation (TNT) reticulocyte lysate system was used to examine posttranslational alterations in
HIV-1 Gag upon addition of Jurkat T cell membranes. Incubation of the Gag precursor protein, Pr55gag, with membranes
resulted in a time-dependent alteration in Gag resulting in partial resistance to trypsin treatment. Treatment of membranes
and TNT extract with apyrase or pretreatment of membranes with trypsin prevented this posttranslational alteration of Gag.
In contrast, this activity was not disrupted by pretreatment of membranes with Triton X-100 at 4°C, under conditions which
do not solubilize raft-associated proteins. Flotation studies revealed that acquisition of trypsin-resistance was accompanied
by Gag binding to membranes. The myristylation signal and nucleocapsid domain were found to mediate Gag binding to
membranes. The posttranslational alteration of Gag accompanying membrane interaction may represent a conformational
change, oligomerization, and/or association with or envelopment by membranes. These findings provide new clues to theKey Words: HIV-1; Gag; membranes.
INTRODUCTION
The Gag protein directs the assembly of type c retro-
virus particles at the plasma membrane (Freed, 1998;
Krausslich and Welker, 1996; Swanstrom and Wills,
1997). HIV-1 Gag is synthesized as a 55-kDa myristylated
precursor protein, Pr55gag, that is cleaved by the viral
protease into p17 matrix (MA), p24 capsid (CA), p9 nu-
cleocapsid (NC), p6, and intervening p1 and p2 spacer
peptides. Particle assembly depends on the coordinated
action of a membrane-targeting domain provided by MA,
a protein and RNA interaction domain provided by NC,
and a late budding domain included within p6. Mem-
brane targeting occurs during or after Gag multimeriza-
tion (Ono et al., 2000; Platt and Haffar, 1994) and involves
a basic domain at the N-terminus of MA together with the
myristyl modification (Bryant and Ratner, 1990; Gottlinger
et al., 1989; Spearman et al., 1994; Zhou et al., 1994).
Subsequently, Gag assembly occurs within membrane
microdomains, known as lipid rafts (Ono and Freed,
2001).
Cell-free synthesis systems have been used to char-
acterize retrovirus assembly, including Gag protein ex-
pressed in Escherichia coli, or wheat-germ or reticulo-
cyte lysates (Campbell et al., 2001; Campbell and Rein,
1999; Campbell and Vogt, 1995; Ganser et al., 1999;
Gross et al., 2000; Klikova et al., 1995; Morikawa et al.,
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1641999; Platt and Haffar, 1994; Sakalian et al., 1994; Singh
et al., 2001; Spearman and Ratner, 1996; vonSchwedler et
al., 1998). Although CA alone is capable of forming mul-
timeric complexes (Ehrlich et al., 2001), the size and
shape of these complexes is modified by the inclusion of
flanking Gag residues (vonSchwedler et al., 1998). Sev-
eral studies have also indicated an important role of
nucleic acids in the assembly process (Campbell and
Vogt, 1995; Muriaux et al., 2001). In addition, cellular
factors, such as inositol phosphate, have been shown to
contribute to cell-free assembly of retrovirus-like parti-
cles (Campbell et al., 2001). Moreover, these studies
have shown that assembly is a stepwise, ATP-dependent
process, with specific intermediates (Lingappa et al.,
1997; Morikawa et al., 1999; Singh et al., 2001; Zimmer-
man et al., 2002). However, these previous studies have
been restricted to examining structural alterations of Gag
that occur during viral capsid formation. The current
study extends these cell-free studies by examining the
interaction of Gag with membranes.
RESULTS
Interaction with membranes results in resistance of
Gag to trypsin treatment
To examine the consequences of Gag interaction with
membranes, a cell-free system was utilized. Pr55gag
was translated using the transcription-translation (TNT)
reticulocyte lysate system from plasmid 55G1 (Fig. 1A).
Pr55gag synthesis was linear over the 90-min period (notstepwise process of HIV-1 assembly. © 2002 Elsevier Science
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doi:10.1006/viro.2002.1532shown). Addition of 31 g/ml micrococcal nuclease was
effective in terminating translation, as shown by the ad-(USA)
dition of micrococcal nuclease at the initiation of the
reaction, which resulted in no Gag protein (not shown). A
p41 Gag product was also identified that could be im-
munoprecipitated with anti-p24 antiserum (not shown).
Pulse-chase analysis did not demonstrate processing of
Pr55gag into p41 (not shown), suggesting that the
smaller product arose from utilization of an alternative
initiation codon and/or premature translational termina-
tion. A similar species has been identified previously
(Platt and Haffar, 1994).
Pr55gag was susceptible to proteolytic digestion with
trypsin (Fig. 1A). Only 10% of Pr55gag remained after
addition of 4 g/ml of trypsin for 20 min (Fig. 1B), and
none after addition of 8 g/ml trypsin. Although the
p41gag product was more resistant to trypsin than
Pr55gag, no detectable Gag protein was detectable after
incubation with 12 g/ml trypsin.
To examine Gag processing, after synthesis of
Pr55gag for 90 min, micrococcal nuclease was added
and the reaction incubated for up to 24 h (Fig. 1A). Over
this time period, Pr55gag was stable (Fig. 1A). Trypsin
sensitivity of Pr55gag was only slightly decreased after
24 h incubation, with 40% of Pr55gag remaining after
treatment with 4 g/ml trypsin, and 5% Pr55gag remain-
ing after treatment with 8 g/ml trypsin (Fig. 1B).
The effect of addition of membrane preparations from
Jurkat cells or 293T cells (not shown) was next examined
(Fig. 1A). Concentrations of membranes of up to 500
g/ml protein did not affect Pr55gag synthesis. More-
over, trypsin-sensitivity of Pr55gag synthesized over 90
FIG. 1. Partial trypsin resistance of Pr55gag incubated with membranes. Pr55gag was synthesized using the coupled transcription/translation
reticulocyte lysate system. Membranes isolated from Jurkat T cells were added to the system at the beginning of the translation reaction to a final
concentration of 0.5 mg/ml. The reaction was effectively terminated by adding micrococcal nuclease at 1.5 h posttranslation. (A) Incubation was
continued for an additional 24 h for the experiments shown on the right. Samples were digested with the indicated concentrations of trypsin and then
subjected to centrifugation through a 20% sucrose cushion followed by SDS–PAGE and autoradiography. (B) The proportion of Pr55gag after trypsin
digestion was quantitated by densitometry using NIH program 1.61. (C) Samples were taken at different times after the 1.5 h translation reaction and
treated with 0, 4, 8, 12, 16, or 20 g/ml trypsin as previously described. The endpoint for trypsin resistance is the highest concentration of trypsin at
which at least 3% of Pr55gag is undigested.
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min in the presence of membranes was similar to that of
Pr55gag synthesized in the absence of membranes.
However, continued incubation of Pr55gag with mem-
branes resulted in increasing trypsin-resistance with
time (Fig. 1C). After 24 h of incubation, 4 g/ml trypsin
resulted in 90% of Pr55gag remaining intact; 8 ug/ml
trypsin resulted in 60% of Pr55gag remaining intact, and
12 g/ml trypsin resulted in 30% of Pr55gag remaining
intact. Higher concentrations of trypsin, or longer incu-
bations with 12 g/ml trypsin, resulted in complete di-
gestion of Gag proteins (not shown). Addition of 0.5%
Triton X-100 after 24 h of incubation of Gag with mem-
branes resulted in sensitivity to trypsin (not shown). Sim-
ilar findings were obtained with the addition of mem-
branes after Pr55gag synthesis, rather than during
Pr55gag synthesis (not shown).
It seems unlikely that membrane proteins were com-
peting with Pr55gag for cleavage by limiting amounts of
trypsin, since resistance to trypsin required incubation
for 90 min. To further address this possibility, equiva-
lent amounts of bovine serum albumin were added to
Pr55gag and incubated for up to 24 h, which did not
result in trypsin resistance (not shown). Addition of CaCl2
up to 15 mM or myristyl CoA up to 10 M did not alter the
amount of Pr55gag synthesized or its sensitivity to tryp-
sin when incubated in the presence or absence of mem-
branes (not shown).
These results suggest that under these cell-free reac-
tion conditions, Gag undergoes a posttranslational alter-
ation that results in trypsin resistance. This may repre-
sent a conformational change, oligomerization, and/or
association with or envelopment by membranes.
ATP-dependence of membrane-dependent
posttranslational change in Pr55gag
Since the posttranslational alteration of Pr55gag that
occurred in the presence of membrane was time-depen-
dent, we also asked whether this process was ATP-
dependent. For this purpose, we added the enzyme
apyrase, under conditions that depleted ATP. Addition of
apyrase at the initiation of translation blocked the syn-
thesis of Pr55gag (not shown). Addition of apyrase after
90 min of Pr55gag synthesis had no effect on the stability
of Pr55gag, or on its susceptibility to trypsin digestion
(not shown). However, addition of apyrase prevented the
posttranslational alteration of Pr55gag that occurred in
the presence of membranes, as indicated by the devel-
opment of trypsin-resistance (Fig. 2, compare the right-
hand panel with the middle panel and the left-hand
panel).
Effect of membrane pretreatment on posttranslational
change in Pr55gag
The posttranslational alteration of Pr55gag occurred
after incubation with membranes and resulted in partial
trypsin-resistance. Pretreatment of the membrane prep-
aration with 1 M NaCl, prior to dialysis, under conditions
that would remove peripheral membrane proteins, did
not have an effect on the posttranslational alteration of
Pr55gag (Fig. 3, upper middle panel). Moreover, pretreat-
ment of the membrane preparation with 0.5% Triton X-100
at 4°C prior to dialysis, under conditions that would
solubilize non-raft-associated proteins, also did not have
an effect on the posttranslational alteration of Pr55gag
(Fig. 3, upper right panel). In contrast, pretreatment with
250, 500, or 1000 g/ml trypsin for 20 min at 37°C
eliminated the ability of the membrane preparations to
promote the posttranslational modification of Pr55gag
(Fig. 3, lower panels). These findings suggest that an
integral membrane protein, perhaps associated with
lipid rafts, may be critical for Pr55gag to undergo a
posttranslational alteration that results in partial trypsin-
resistance.
FIG. 2. ATP depletion inhibited posttranslation alteration of Pr55gag. Pr55gag was synthesized using the coupled transcription/translation
reticulocyte lysate system in the presence of Jurkat T cell membranes. The reaction was terminated by adding micrococcal nuclease at 1.5 h
posttranslation. The products were divided into three parts. One part was mixed with apyrase (1 u/l) and incubated for an additional 24 h. A second
part was incubated for an additional 24 h without the addition of apyrase. The third part was neither incubated further nor supplemented with apyrase.
Samples were treated with the indicated concentration of trypsin, subjected to ultracentrifugation, SDS–PAGE, and autoradiography.
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Gag association with membranes
To examine the association of Pr55gag with mem-
branes, flotation experiments were performed. For this
purpose, each sample was placed at the bottom of a
tube containing a step gradient of 10/65% sucrose. After
centrifugation, membrane-associated protein is found at
the sucrose interface, fractions 3–4, and protein not as-
sociated with membranes remains at the bottom of the
tube, fractions 9–10 (Fig. 4A). Expression of Pr55gag in
TNT extracts and incubation for 24 h resulted in 27% of
the Gag protein at the 10/65% sucrose interface, presum-
ably due to interaction with membranes in the TNT ex-
tract. Addition of Jurkat cell membranes during the 24 h
incubation after synthesis of Pr55gag resulted in 70% of
Gag at the 10/65% sucrose interface. Treatment of the
reaction mixtures with 0.5% Triton X-100 disrupted the
membrane-binding activity, whereas treatment with 1 M
NaCl had no effect (Fig. 4A). The Gag protein obtained
from fractions 3–4 after incubation with membranes
demonstrated relative trypsin-resistance compared to
that in fractions 9–10 (Fig. 4B).
Gag determinants of membrane association and
posttranslational alteration
We sought to determine which domains of Pr55gag
were required for membrane interaction. For this pur-
pose, we utilized several deletion mutants of Pr55gag,
which had previously been examined in transfected cells
for membrane association and retrovirus-like particle
formation (Fig. 5). In previous studies, the 55G1 protein
expressed in HeLa cells was found to interact with mem-
branes isolated under low (150 mM NaCl) or high salt
conditions (1 M NaCl) and formed retrovirus-like parti-
cles with similar density, size, and morphology to those
produced in HIV-1-infected cells treated with a protease
inhibitor (Spearman et al., 1994). Membrane association
studies were performed in the previous studies at differ-
ent salt conditions to assess the affinity of Gag interac-
tion with membranes. The 41G1A product is character-
ized by a deletion of p6 and the portion of the NC that
includes the second zinc finger domain. In transfected
cells, it had similar membrane association and particle
formation activities as that produced by 55G1. The 41G1B
protein has a deletion of the entire p6 and NC domains.
It formed no detectable particles in our experimental
system, but this protein was not previously evaluated for
membrane association. The 39G1 product has a deletion
of amino acid residues 16–132 of MA, leaving the myri-
stylation signal intact. It formed intracellular but no de-
tectable extracellular particles in HeLa cells and could
not be analyzed for membrane association by this ultra-
centrifugation assay. The 24G1, 17G1, and 15G1 proteins
included only the CA, MA, and NC-p6 domains, respec-
tively, with the first 15 amino acids of the MA domain
providing a myristylation signal. The 17G1 protein inter-
FIG. 3. Effect of membrane pretreatments on posttranslational changes in Pr55gag. Aliquots of Jurkat T cell membranes were treated with 0.5% (v/v)
Triton X-100 or 1 M NaCl for 1 h on ice, or with 250, 500, or 1000 g/ml trypsin at 37°C for 20 min, or left as a control. The membranes were
subsequently washed five times with translation buffer and resuspended in their original volumes. The membranes were then added during Pr55gag
synthesis and samples taken after 1.5 h, or 24 h after termination of Pr55gag synthesis. Samples were treated with the indicated concentrations of
trypsin, subjected to ultracentrifugation, SDS–PAGE, and autoradiography.
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acted with membranes under high salt conditions, but
formed retrovirus-like particles inefficiently (Wang et al.,
2000). In contrast, neither 24G1 or 15G1 proteins inter-
acted with membranes under high salt conditions or
formed retrovirus-like particles.
We also examined site directed mutants of each of the
proteins, in which the myristylation acceptor Gly residue
at the N-terminus of Gag was changed to an Ala residue
and designated with an “A1.” The 55A1 and 41A1 proteins
could interact with membranes under low salt condi-
tions, but not high salt conditions, and formed no detect-
able virus-like particles in HeLa cells. The 39A1 product
formed intracellular particles indistinguishable from
those produced from the 39G1 protein. The 24A1, 17A1,
and 15A1 proteins did not form retrovirus-like particles
and did not associate with membranes.
Each mutant protein was also examined in the cell-
free system supplemented with Jurkat cell membranes.
The 55G1, 41G1A, 41G1B, and 39G1 proteins all exhibited
membrane-binding activity, with 49, 47, 38, and 45%,
respectively, of the product associated with membranes
at the 10/65% sucrose interface (Fig. 5). Moreover, 55A1
and 41A1 also exhibited membrane-binding activity with
36 and 38%, respectively, of the product at the sucrose
interface. In addition, 39A1 also exhibited membrane-
binding activity with 30% of the protein at the sucrose
interface.
Notable differences were seen with 24G1 and 17G1,
which exhibited membrane-binding activity (33 and 32%
at the sucrose interface, respectively), whereas 24A1
and 17A1 had no membrane-binding activity. Both 15G1
and 15A1 exhibited membrane-binding activity, with 41
and 30%, respectively, associated with membranes at the
sucrose interface.
DISCUSSION
What is the nature of the posttranslational alteration
in Gag occurring in the cell-free system?
Cell-free synthesis of the Gag precursor protein in
reticulocyte lysates resulted in a predominant product of
the expected molecular mass or 55 kDa, and a minor
41-kDa product (p41) arising from a downstream trans-
lational initiation codon or as a result of premature trans-
lational termination (Fig. 1). Alternatively, p41 may have
arisen from translation of an alternative truncated RNA
species produced in the coupled transcription-transla-
tion system. We cannot exclude the possibility that the
41-kDa protein is capable of interaction with Pr55gag
and affects its activity.
Pr55gag is myristylated in infected or transfected cells.
We have previously shown that Pr55gag produced in
reticulocyte lysates is also myristylated, but we have not
directly compared the stoichiometry of myristylation of
Pr55gag expressed from whole cells to that produced in
the cell-free expression system. We and others have also
demonstrated that Pr55gag is phosphorylated in whole
cells, but we did not examine this modification in
Pr55gag produced in the cell-free system.
Incubation of Pr55gag with membranes in the cell-free
FIG. 4. Flotation analysis of Pr55gag interaction with membranes. (A) Pr55gag was translated with or without membranes at 30°C for 1.5 h and
reaction was termination by the addition of micrococcal nuclease. Samples were treated at room temperature for 10 min with either 1 M NaCl or 0.5%
(v/v) Triton X-100, or left untreated as a control. Samples were then mixed in a 1:6 ratio with 85% (wt/vol) sucrose, overlaid with 65 and 10% sucrose,
and subjected to ultracentrifugation at 100,000 g for 18 h. Ten fractions were collected from the top, diluted with PBS, and immunoprecipitated with
rabbit anti-CA antiserum, subjected to SDS–PAGE, and visualized by autoradiography. (B) Samples from fractions 3–4 and 9–10 of the sucrose gradient
of untreated sample of Pr55gag incubated with membranes were each divided into two parts. One part was treated with 4 g/ml trypsin at 37°C for
20 min and the other part left untreated as a control. The resulting samples were subjected to SDS–PAGE and autoradiography.
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system resulted in a posttranslational alteration charac-
terized by partial resistance to trypsin treatment (Fig. 1)
and incomplete trypsin-resistance compared to that of
Pr55gag within the core of virions (Spearman and Ratner,
1996). The posttranslation alteration could represent a
conformational change in monomeric Gag protein. A
conformational change in Gag may alter exposure of the
myristyl moiety and/or other membrane association do-
mains (Spearman and Ratner, 1996; Zhou and Resh,
1996)
Alternatively, the posttranslational alteration may rep-
resent a change in the conformation of the viral core
similar to those that occur in vitro with bacteriophages
(Conway et al., 2001; Lata et al., 2000) or herpes simplex
virus capsids (Newcomb et al., 2000). In the case of
herpes virus capsids, incubation at 21°C for 72 h was
required for full procapsid transformation. The slower
kinetics of herpes capsid formation in vitro compared to
infected insect cells was suggested to be due to the
presence of cellular factors that promote the assembly
process. Similar requirements are likely to exist for HIV-1
assembly (Bieniasz and Cullen, 2000; Mariani et al.,
2000; Parker and Hunter, 2000; VerPlank et al., 2001).
Alternatively, the posttranslational modification of Gag
may be due to direct or indirect effects of membrane
association. It is possible that membranes interact with
trypsin cleavage sites of Pr55gag, thus conferring partial
protease sensitivity.
Why is the posttranslational alteration in Gag
an ATP-dependent process?
ATP depletion has been shown to disrupt assembly of
diverse viruses. Cobbold and colleagues showed the
involvement of ATP and calcium stores in the envelop-
ment of African swine fever virus by the endoplasmic
reticulum membrane (Cobbold et al., 2000). Copeland
and colleagues demonstrated that folding, trimerization,
FIG. 5. Membrane association of mutant Gag proteins. The top left shows a schematic representation of the positions of MA, CA, NC, and p6
domains within Pr55gag. The portions of Pr55gag present in each mutated protein are shown by the shaded lines. The jagged line at the left of the
shaded figures indicates the presence of the myristyl moiety. Results obtained with each of these mutants in whole cells using a vaccinia virus
expression system are listed (Spearman et al., 1994). Membrane association was determined by the ability of Gag protein to cosediment with
membranes at 100,000 g, and particle formation was determined by sucrose gradient density and electron microscopic analyses. Results of cell-free
experiments performed with each Gag mutant are shown on the right. All of the Gag proteins were translated in the presence of membranes and
incubated at 30°C for an additional 24 h. To increase membrane binding, 4 mg/ml membranes was added and incubated at 30°C for an additional
2 h. Samples were analyzed by flotation as previously described.
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and transport were sequential energy-dependent events
in the biogenesis of influenza virus hemagglutinin (Cope-
land et al., 1988). Barman and colleagues showed that
ATP hydrolysis was required for influenza budding (Bar-
man et al., 2001). Doms and colleagues demonstrated a
role for ATP in the assembly and transport of vesicular
stomatitis virus G protein trimers. Dasgupta and Wilson
demonstrated ATP depletion blocks herpes simplex virus
DNA packaging and capsid maturation (VerPlank et al.,
2001).
In studies of retroviruses, Weldon and colleagues
demonstrated that ATP depletion blocked type D retrovi-
rus transport to the plasma membrane and release (Wel-
don et al., 1998). It is unclear whether this was due to an
ATP requirement for a chaperone to transport procapsids
to the plasma membrane or whether it represented an
ATP-dependent conformational change in the procapsid.
It is of interest that an ATP-dependent chaperone, TriC,
has been found to be associated with Gag (Hong et al.,
2001). Tritel and Resh showed that late steps in HIV-1
budding from cells are energy dependent (Tritel and
Resh, 2001). Lingappa demonstrated with a cell-free sys-
tem that one or more steps of HIV-1 assembly were ATP
dependent (Lingappa et al., 1997). They recently demon-
strated that this was at least partially due to interaction of
capsid intermediates with an ATP-binding protein, HP68
(Zimmerman et al., 2002). The role of ATP binding or ATP
hydrolysis in our cell-free system requires further analy-
sis.
What characteristics of the membrane preparation
are critical for the posttranslational alteration of Gag?
The current studies demonstrated that pretreatment of
membranes with Triton X-100 at 4°C did not disrupt the
posttranslational effects of membrane interaction. Treat-
ment of membranes under these conditions fails to sol-
ubilize raft-associated membranes. The role of raft asso-
ciation for HIV and MLV assembly after membrane as-
sociation has been suggested by studies of several
investigators (Lindwasser and Resh, 2001; Nguyen and
Hildreth, 2000; Ono and Freed, 2001; Pickl et al., 2001).
Assembled Gag proteins may be dragged into rafts by
protein–protein interactions or through an increased af-
finity for liquid-ordered phases (vander Goot and Harder,
2001).
Our studies also suggest that an integral membrane
protein is required for posttranslational alteration of Gag,
since trypsin pretreatment of membranes abolished their
activity, whereas 1 M NaCl had no affect (Fig. 3). It is of
interest that a 32-kDa plasma membrane protein was
previously reported as a specific receptor myristylated
src (Resh and Ling, 1990), but there have been no further
reports characterizing this factor. Our findings provide a
means to characterize a cellular protein(s) that facilitates
Gag interaction with membranes and assessment of its
localization in rafts.
What domains of Gag are important for the
posttranslational alteration?
The N-terminal domain of Pr55gag is important for
membrane targeting as well as additional domains in the
MA portion (Ono et al., 2000; Zhou et al., 1994). This may
account for the association of 17G1 and 24G1 with mem-
branes in this cell-free system, whereas the nonmyristy-
lated mutants did not bind membranes. NC has been
shown to interact with cytoskeletal actin (Liu et al., 1999).
Actin or associated actin-binding proteins could serve as
nucleation sites for virus assembly. This may account for
the binding of both 15G1 and 15A1 with membranes in
this cell-free system, as well as the larger Gag proteins
including the following domains, 55G1, 55A1, 41G1, 41A1,
39G1, and 39A1. Similarities were noted between pro-
teins capable of binding membranes in the cell-free
system, as compared to their membrane interactions in
transfected HeLa cells, as assessed under physiological
salt conditions (Spearman et al., 1994). However, no
differences were detected between the membrane-inter-
action activity of 55G1 and 55A1 products in the cell-free
system when analyzed in 1 M NaCl (data not shown).
These differences between the cell-free system and
transfected HeLa cells are likely to result from differ-
ences in myristylation efficiencies, and/or differences in
the kinetics and affinities of different Gag proteins for
membrane association.
Does the posttranslational alteration of Gag model a
process that occurs in infected cells?
Several findings in our cell-free system parallel those
found with HIV-1-infected cells. These include the step-
wise process of assembly through several intermediates,
the requirement for ATP for assembly, and the acquisition
of a protease-resistant nucleoprotein core accompany-
ing nucleocapsid conformational alterations. This cell-
free system may have applications to screening and
characterization of novel inhibitors of HIV-1 assembly.
Further demonstration of the validity of the cell-free
model system requires functional reconstitution of other
components of the virus particle, and ultimately, the cell-
free synthesis of infectious virus particles.
MATERIALS AND METHODS
Cells and antibodies
Jurkat T cells were propagated and maintained in
RPMI 1640 medium supplemented with 10% fetal bovine
serum and 2 mM glutamine. Rabbit anti-p24CA anti-
serum and human anti-HIV sera were used to detect Gag
(Spearman et al., 1994).
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Plasmids
All plasmids were derived from HIV-1 strain HXB2
(Spearman et al., 1994). Plasmids designated pG1 ex-
press Gag proteins with a myristylation-acceptor glycine
at residue 1 at the N-terminus, whereas plasmids des-
ignated pA1 express the identical Gag proteins with a
glycine-to-alanine codon substitution, to remove the
myristylation signal.
Membrane preparations
Membranes were prepared from Jurkat T cells. Cells
(1  108) were harvested by centrifugation at 2000 rpm
for 15 min. Cells were washed twice in translation buffer
(15 mM Tris–HCl, 50 mM KCl, 10 mM K2HPO4, 1 mM
MgCl2, and 10 mM NaCl, pH 7.5), supplemented with 2
mM ethylene glycol-bis(-aminoethylether)-N,N,N,N-
tetraacetic acid (EGTA). Subsequently, cells were resus-
pended in hypotonic buffer (20 mM Tris–HCl, pH 7.5, 10
mM KCl, 1 mM EDTA, 0.1% 2-mercaptoethanol, 2 g/ml
aprotinin), supplemented with EGTA, and incubated at
4°C for 2 h. The cells were then transferred to a Dounce
homogenizer and homogenized for 25 strokes. Cell de-
bris and nuclei were removed by centrifugation for 5 min
at 13,000 rpm in an Eppendorf microfuge. The superna-
tants containing cellular membranes were subsequently
pelleted by centrifugation at 200,000 g in a Beckman
SW55 rotor for 40 min at 4°C. The cellular membranes
were washed twice in translation buffer and resus-
pended and stored in translation buffer at 70°C.
In studies in which pretreatments of membranes were
performed, membranes were treated with 250, 500, or
1000 g/ml trypsin at 37°C for 20 min, with 1 M NaCl at
room temperature for 10 min, or with 0.5% Triton X-100 on
ice for 1 h. Subsequently, the treated membranes were
washed five times in translation buffer by centrifugation
at 200,000 g in a Beckman SW55 rotor for 40 min at 4°C.
The resulting pellets were resuspended in translation
buffer at their original volume.
In vitro transcription-translation
The Gag proteins were transcribed and translated
from plasmid DNA templates using rabbit reticulocyte
lysate (TNT Quick Coupled Transcription/Translation
Systems, Promega, Madison, WI) according to the man-
ufacturer’s protocol. Each reaction contained 40 l TNT
T7 quick master mix consisting of reticulocyte lysate,
amino acids, T7 RNA polymerase, and reaction buffer, 2
l DNA (1 ug/ul), 2 l Redivue L-[35S]methionine (10
mCi/ml) (Amersham Pharmacia Biotech, IL), and 6 l
nuclease-free water. For p17 plasmids, Tran-[35S]label
was used (50 mCi/ml; ICN, CA). The reaction mixture was
incubated at 30°C for 1.5 h. To each reaction, 1 unit
micrococcal nuclease (Sigma Chemical Co., St. Louis,
MO) was added to stop translation. The incubation was
extended for the times indicated. For some reactions, the
following agents were added: 10 M myristyl CoA
(Sigma) at the beginning of translation or 1 u/l apyrase
or 5, 10, or 15 mM CaCl2 at 1.5 h posttranslation.
Membrane association assay
Fifty microliters of in vitro reaction was mixed with an
equal volume of membranes (1 mg/ml) or with translation
buffer at the beginning of translation or after 1.5 h. The
mixtures were incubated at 30°C. Aliquots were taken at
time points as indicated, digested with trypsin, and pro-
cessed as described below. Alternatively, 50 l of in vitro
reaction was mixed with an equal volume of membranes
(3 mg/ml) or translation buffer at 1.5 h posttranslation,
and the mixtures were incubated for another 2 h at 30°C.
The mixtures were subject to flotation assay as de-
scribed below.
Trypsin digestion
The Gag products translated with or without mem-
branes were divided into 10-l aliquots. Aliquots were
mixed with 0, 4, 8, 12, 16, or 20 g/ml trypsin (Sigma) and
incubated at 37°C for 20 min. Trypsin digestion was
stopped by adding 2 l trypsin inhibitor (10 mg/ml,
Sigma). Subsequently, mixtures were layered over a 20%
sucrose cushion in 0.01 M phosphate-buffered saline
(PBS) and centrifuged at 200,000 g in a Beckman SW55
rotor for 40 min at 4°C. The pelleted Gag protein was
subject to SDS–PAGE and autoradiography.
Flotation assays
Flotation assays were performed as described previ-
ously (Spearman et al., 1997). One hundred microliters of
translation mixture with or without membranes was
mixed with 0.6 ml of 85% sucrose (wt/vol) in PBS and
layered at the bottom of tubes. Some reactions were
mixed with an equal volume of 2 M NaCl and incubated
at room temperature for 10 min, prior to flotation assay.
Other reaction mixtures were treated with 0.5% Triton
X-100 at room temperature for 10 min prior to flotation
assay. In each case, 2.3 ml of 65% sucrose (wt/vol) and 1
ml of 10% sucrose (wt/vol) were overlaid. Centrifugation
was at 100,000 g for 18 h at 4°C in a Beckman SW55
rotor. Ten fractions were collected from the top of each
sample. The fractions were diluted with PBS, and Gag
proteins were precipitated with rabbit anti-p24CA anti-
serum, followed by SDS–PAGE and autoradiography.
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